Attributable Mortality of Nosocomial Candidemia, Revisited
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These infections are associated with attributable mortality rates that have ranged from 38% between 1983 and 1986 (46) to 49% in the same institutions between 1997 and 2001 (13).”
In the citing paper
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in controls; the resulting ''attributable mortality'' was therefore estimated to be 49%.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [12]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Research works printed but not linked: 3
- Harvey, 1987, Archives of Internal Medicine, 147, 2117, 10.1001/archinte.1987.00370120053011 · doi:10.1001/archinte.1987.00370120053011
- Martin, 1989, Annals of Internal Medicine, 110, 9, 10.1059/0003-4819-110-1-9 · doi:10.1059/0003-4819-110-1-9
- O'Grady, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 51, 1
Cited by
Items 401–500 of 1,000
Ahmad, S., Mustafa, A. S., Khan, Z., Al-Rifaiy, A. I., & Khan, Z. U. (2004) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.01.002 · Cited by 47
Transcriptome Profile of the Vascular Endothelial Cell Response toCandida albicans
Barker, K. S., Park, H., Phan, Q. T., Xu, L., Homayouni, R., Rogers, P. D., & Filler, S. G. (2008) · The Journal of Infectious Diseases · doi:10.1086/589516 · Cited by 47
Echinocandins: role in antifungal therapy, 2005
Zaas, A. K., & Alexander, B. D. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.10.1657 · Cited by 47
Invasive candidiasis and candidemia: from current opinions to future perspectives
Rüping, M., Vehreschild, J. J., & Cornely, O. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902911440 · Cited by 47
Berdal, J., Haagensen, R., Ranheim, T. E., & Bjørnholt, J. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103916 · Cited by 46
Rosseti, I. B., da Rocha, J. B. T., & Costa, M. S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.08.001 · Cited by 46
Gao, Y., Zhang, C., Lu, C., Liu, P., Li, Y., Li, H., & Sun, S. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12048 · Cited by 39
Posaconazole: a new broad-spectrum antifungal agent
Kwon, D. S., & Mylonakis, E. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1167 · Cited by 46
NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
Alqarihi, A., Singh, S., Edwards, J. E., Ibrahim, A. S., & Uppuluri, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-42517-y · Cited by 45
Magill, S. S., Swoboda, S. M., Shields, C. E., Colantuoni, E., Fothergill, A. W., Merz, W. G., Lipsett, P. A., & Hendrix, C. W. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819ed914 · Cited by 45
Emerging drugs and vaccines for Candidemia
Moriyama, B., Gordon, L. A., McCarthy, M. W., Henning, S. A., Walsh, T. J., & Penzak, S. R. (2014) · Mycoses · doi:10.1111/myc.12265 · Cited by 45
Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013
Motoa, G., Muñoz, J. S., Oñate, J., Pallares, C., Hernández, C., & Villegas, M. V. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.006 · Cited by 45
Posaconazole in the management of refractory invasive fungal infections
Neumeister, P. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3329 · Cited by 44
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.08.001 · Cited by 44
Zuluaga, A., Gómez, C. D. B., Restrepo, C. A. A., Parra, H. H., Arteaga, M. A., Moreno, Á. R., & Marín, Á. G. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.04.001 · Cited by 44
Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis
Hall, A., Poole, L., Renton, B., Wozniak, A., Fisher, M., Neal, T. J., Halloran, C. M., Cox, T. F., & Hampshire, P. A. (2013) · Critical Care · doi:10.1186/cc12569 · Cited by 44
Laín, A., Moragues, M. D., García‐Ruiz, J. C., Mendoza, J., Camacho, A., del Palacio, A., & Pontón, J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-06 · Cited by 44
Vasicek, E. M., Berkow, E. L., Bruno, V. M., Mitchell, A. P., Wiederhold, N. P., Barker, K. S., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-14 · Cited by 36
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors
Boo, T. W., O’Reilly, B., O'Leary, J. P., & Cryan, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01134.x · Cited by 44
A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans
Vargas-Blanco, D. A., Lynn, A., Rosch, J. C., Noreldin, R. M., Salerni, A. A., Lambert, C., & Rao, R. P. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0215-z · Cited by 44
Hope, W. W., Drusano, G. L., Moore, C. B., Sharp, A., Louie, A., Walsh, T. J., Denning, D. W., & Warn, P. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00601-06 · Cited by 40
Simvastatin inhibits Candida albicans biofilm in vitro
Liu, G., Vellucci, V. F., Kyc, S., & Hostetter, M. K. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181bd5bf8 · Cited by 43
Chromatin-mediated Candida albicans virulence
da Rosa, J. L., & Kaufman, P. D. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.08.007 · Cited by 43
Hoffmann‐Santos, H. D., Paula, C. R., Yamamoto, A. C. A., Tadano, T., & Hahn, R. C. (2013) · Mycopathologia · doi:10.1007/s11046-013-9705-5 · Cited by 43
Epidemiology and prognostic factors of candidemia in elderly patients
Tang, H., Liu, W., Lin, H.-L., & Lai, C. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12329 · Cited by 43
Orasch, C., Weisser, M., Mertz, D., Conen, A., Heim, D. A., Christen, S. E., Gratwohl, A. A., Battegay, M., Widmer, A. F., & Flückiger, U. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.187 · Cited by 43
Karlowsky, J. A., Hoban, D. J., Zhanel, G. G., & Goldstein, B. P. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.10.014 · Cited by 43
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Horn, D. L., Neofytos, D., Pfaller, M. A., & Diekema, D. J. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.007 · Cited by 43
Self-citationToussaint, B., Lanternier, F., Woloch, C., Fournier, D., Launay, M., Billaud, E. M., Dannaoui, É., Lortholary, O., & Jullien, V. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.01.036 · Cited by 43
Luo, S., Dasari, P., Reiher, N., Hartmann, A., Jacksch, S., Wende, E., Barz, D., Niemiec, M. J., Jacobsen, I. D., Beyersdorf, N., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.07.010 · Cited by 43
Terlecká, J., du Cros, P., Morrissey, C. O., & Spelman, D. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01307.x · Cited by 43
Yu, Q., Jia, C., Dong, Y., Zhang, B., Xiao, C., Chen, Y., Wang, Y., Li, X., Wang, L., Zhang, B., et al. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.02.008 · Cited by 42
“Nowadays, the frequency of opportunistic fungal infections is on the rise, due to the growing population of immunocompromised patients and those individuals suffered from organ transplantation, chemotherapy or antibiotic abuse (LaFayette et al., 2010; Gudlaugsson et al., 2003; Wisplinghoff et al., 2004).”
BackgroundTakakura, S., Fujihara, N., Saito, T., KIMOTO, T., Ito, I., Iinuma, Y., & Ichiyama, S. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/504934 · Cited by 42
Candidemias: análisis multicéntrico en 16 hospitales andaluces
Rodríguez-Hernández, M. J., de Pipaón, M. R.-P., Márquez, M., Martín-Rico, P., Castón, J. J., Guerrero-Sánchez, F., Vidal-Verdú, E., Garcia-Figueras, C., del Arco, A., Rodríguez‐Baño, J., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2010.12.003 · Cited by 42
Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality
Bader, M. S., Lai, S. M., Kumar, V., & Hinthorn, D. R. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021126 · Cited by 42
A phagocytic cell line markedly improves survival of infected neutropenic mice
Spellberg, B. J., Collins, M., French, S. W., Edwards, J. E., Fu, Y., & Ibrahim, A. S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205072 · Cited by 43
Uppar, V., Chandrashekharappa, S., Shivamallu, C., Pradeep, S., Kollur, S. P., Ortega‐Castro, J., Frau, J., Flores‐Holguín, N., Basarikatti, A. I., Chougala, M. B., et al. (2021) · Molecules · doi:10.3390/molecules26092722 · Cited by 41
Genetic Control of Susceptibility to Infection with Candida albicans in Mice
Radovanovic, I., Mullick, A., & Gros, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018957 · Cited by 41
Clinical significance of the isolation of Candida species from hospitalized patients
Diniz, Y. C. M., Bomfim, M. R. Q., Melônio, L. C., Ribeiro, P. C. S., Cosme, L. M., Rhoden, C. R., & Marques, S. G. (2015) · Brazilian Journal of Microbiology · doi:10.1590/s1517-838246120120296 · Cited by 41
A small molecule inhibitor of fungal histone acetyltransferase Rtt109
da Rosa, J. L., Bajaj, V., Spoonamore, J. E., & Kaufman, P. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.112 · Cited by 41
Lipiński, T., Wu, X., Sadowska, J., Kreiter, E., Yasui, Y., Cheriaparambil, S., Rennie, R. P., & Bundle, D. R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.010 · Cited by 41
Increase in Candida parapsilosis Fungemia in Critical Care Units: A 6-Years Study
Horasan, E. Ş., Ersöz, G., GÖKSU, M., Otaǧ, F., Kurt, A., Karaçorlu, S., & Ali Hakan, K. A. Y. A. (2010) · Mycopathologia · doi:10.1007/s11046-010-9322-5 · Cited by 40
Invasive candidiasis and candidaemia in neonates and children: update on current guidelines
Tragiannidis, A., Tsoulas, C., & Groll, A. H. (2014) · Mycoses · doi:10.1111/myc.12268 · Cited by 40
Apoptosis-inducing antifungal peptides and proteins
Brucker, K. D., Cammue, B. P. A., & Thevissen, K. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391527 · Cited by 40
Barac, A. M., Çevik, M., Čolović, N., Leković, D., Stevanović, G., Micić, J., & Rubino, S. (2020) · Mycoses · doi:10.1111/myc.13048 · Cited by 40
Reda, N. M., Hassan, R. M., Salem, S. T., & Yousef, R. (2022) · Infection · doi:10.1007/s15010-022-01888-7 · Cited by 40
Risk Factors Affecting In-hospital Mortality in Patients with Nosocomial Infections
Sheng, W., Wang, J., Lin, M.-S., & Chang, S. (2007) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60226-6 · Cited by 40
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 40
Gazendam, R. P., van de Geer, A., van Hamme, J. L., Tool, A. T. J., van Rees, D. J., Aarts, C. E. M., van den Biggelaar, M., van Alphen, F. P. J., Verkuijlen, P., Meijer, A. B., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136630 · Cited by 40
Antifungal bromopyrrole alkaloids from the South China Sea sponge Agelas sp.
Zhu, Y., Wang, Y., Gu, B., Yang, F., Jiao, W., Hu, G.-H., Yu, H., Han, B., Zhang, W. Y., Shen, Y., et al. (2016) · Tetrahedron · doi:10.1016/j.tet.2016.04.020 · Cited by 40
Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels
Zhang, M., Chang, W., Shi, H., Zhou, Y., Zheng, S., Li, Y., Li, L., & Lou, H. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.03.004 · Cited by 40
SSD1 Is Integral to Host Defense Peptide Resistance in Candida albicans
Gank, K. D., Yeaman, M. R., Kojima, S., Yount, N. Y., Park, H., Edwards, J. E., Filler, S. G., & Fu, Y. (2008) · Eukaryotic Cell · doi:10.1128/ec.00402-07 · Cited by 40
Louie, A., Stein, D. S., Zack, J., Liu, W., Conde, H., Fregeau, C., VanScoy, B. D., & Drusano, G. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-10 · Cited by 39
Peterson, J. F., Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Riebe, K. M., & Ledeboer, N. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02517-10 · Cited by 39
Self-citationEpidemiology of candidemia and impact of infectious disease consultation on survival and care
Mohr, A., Simon, M., Joha, T., Hanses, F., Salzberger, B., & Hitzenbichler, F. (2020) · Infection · doi:10.1007/s15010-020-01393-9 · Cited by 39
Posaconazole: A Next-Generation Triazole Antifungal
Farowski, F., Vehreschild, J. J., & Cornely, O. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.231 · Cited by 39
A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia
Pasqualotto, A. C., Nedel, W. L., Machado, T., & Severo, L. C. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.12.012 · Cited by 39
Solasodine-3-O-β-d-glucopyranoside kills Candida albicans by disrupting the intracellular vacuole
Chang, W., Li, Y., Zhang, M., Zheng, S., Li, Y., & Lou, H. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.045 · Cited by 38
Thakur, J., & Sanyal, K. (2011) · Eukaryotic Cell · doi:10.1128/ec.05093-11 · Cited by 38
Billack, B., Santoro, M., & Lau‐Cam, C. A. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0872 · Cited by 38
Mukherjee, P. K., Chand, D. V., Chandra, J., Anderson, J. M., & Ghannoum, M. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01632.x · Cited by 38
Zhang, T., & Chen, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091858 · Cited by 37
Ficociello, G., Caris, M. G. D., Trillò, G., Cavallini, D., Sarto, M. S., Uccelletti, D., & Mancini, P. (2018) · Nanomaterials · doi:10.3390/nano8100752 · Cited by 37
Kwon, Y. J., Won, E. J., Jeong, S. H., Shin, K. S., Shin, J. H., Kim, Y. R., Kim, Y. R., Kim, H. S., Kim, Y. A., Kim, T. S., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080597 · Cited by 37
Leelahavanichkul, A., Somparn, P., Bootprapan, T., Tu, H., Tangtanatakul, P., Nuengjumnong, R., Worasilchai, N., Tiranathanagul, K., Eiam‐Ong, S., Levine, M., et al. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00238.2014 · Cited by 37
Bonfietti, L. X., Szeszs, M. W., Chang, M. R., Martins, M. A., Pukinskas, S. R. B. S., Nunes, M. O., Pereira, G. H., Paniago, A. M. M., Purisco, S. U., & Melhem, M. D. S. C. (2012) · Mycopathologia · doi:10.1007/s11046-012-9566-3 · Cited by 37
Risk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study
Schuster, M. G., Meibohm, A. R., Lloyd, L., & Strom, B. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.11.002 · Cited by 37
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 37
A cluster of Candida kruseiinfections in a haematological unit
Hautala, T., Ikäheimo, I., Husu, H., Säily, M., Siitonen, T., Koistinen, P., Vuopio‐Varkila, J., Koskela, M., & Kujala, P. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-97 · Cited by 37
Tati, S., Li, R., Puri, S., Kumar, R., Davidow, P., & Edgerton, M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01851-13 · Cited by 36
Kakeya, H., Yamada, K., Kaneko, Y., Yanagihara, K., Tateda, K., Maesaki, S., Takesue, Y., Tomono, K., Kadota, J.-I., Kaku, M., et al. (2018) · Medical Mycology Journal · doi:10.3314/mmj.17-00014 · Cited by 36
Copper in infectious disease: Using both sides of the penny
Culbertson, E. M., & Culotta, V. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.003 · Cited by 36
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch29 · Cited by 36
Self-citationChen, K.-W., Chen, Y., Lin, Y.-H., Chou, H.-H., & Li, S. (2009) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2009.06.011 · Cited by 36
Candidiasis — Do we need to fight or to tolerate theCandida fungus?
Raška, M., Běláková, J., Křupka, M., & Weigl, E. (2007) · Folia Microbiologica · doi:10.1007/bf02931313 · Cited by 36
Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong.
Yap, H., Kwok, K. M., Gomersall, C. D., Fung, S., Lam, T. C., Leung, P. N., Hui, M., & Joynt, G. M. (2009) · PubMed · Cited by 36
Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis
van de Veerdonk, F. L., Kullberg, B. J., & Netea, M. G. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03676.x · Cited by 36
Predictors of adverse outcome from candidal infection in a tertiary care hospital
Ben‐Abraham, R., Keller, N., Teodorovitch, N., Barzilai, A., Harel, R., Barzilay, Z., & Paret, G. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.02.015 · Cited by 36
Recent advances in antifungal pharmacotherapy for invasive fungal infections
Gallagher, J. C., MacDougall, C., Ashley, E. S. D., & Perfect, J. R. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.253 · Cited by 36
Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study
Alobaid, K., Ahmad, S., Asadzadeh, M., Mokaddas, E. M., Al‐Sweih, N., Benwan, K. A., Alfouzan, W. A., Al‐Obaid, I., Jeragh, A., Al-Roomi, E., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080673 · Cited by 35
Hayama, K., Ishibashi, H., Ishijima, S. A., Niimi, K., Tansho, S., Ono, Y., Monk, B. C., Holmes, A. R., Harding, D. R. K., Cannon, R. D., et al. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02490.x · Cited by 34
Emerging Role of Candida in Deep Sternal Wound Infection
Modrau, I. S., Ejlertsen, T., & Rasmussen, B. S. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.08.012 · Cited by 35
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus
Abadio, A. K. R., Kioshima, É. S., Leroux, V., Martins, N. F., Maigret, B., & Felipe, M. S. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142926 · Cited by 35
Magri, M. M. C., Gomes‐Gouvêa, M. S., de Freitas, V. L. T., Motta, A. L., Moretti, M. L., & Shikanai‐Yasuda, M. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02366-12 · Cited by 35
Epidemiología de las candidiasis invasoras en población pediátrica y adulta
del Palacio, A., Villar, J., & Alhambra, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70002-6 · Cited by 35
Zheng, Y., Xie, T., Wu, L., Liu, X.-Y., Zhu, L. Y., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00441-y · Cited by 34
Velasco, E., Soares, M., Byington, R., Martins, C. A. S., Schirmer, M. R., Dias, L. M. C., & Gonalves, V. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1181-x · Cited by 34
Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
Neofytos, D., Huprikar, S. S., Reboli, A. C., Schuster, M. G., Azie, N. E., Franks, B., & Horn, D. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1939-0 · Cited by 34
Copper-dependent transcriptional regulation by Candida albicans Mac1p
Woodacre, A., Mason, R. P., Jeeves, R. E., & Cashmore, A. M. (2008) · Microbiology · doi:10.1099/mic.0.2007/013441-0 · Cited by 34
Ecological structuring of yeasts associated with trees around Hamilton, Ontario, Canada
Maganti, H. B., Bartfai, D., & Xu, J. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00756.x · Cited by 34
Wang, H., Zhang, L., Kudinha, T., Kong, F., Ma, X.-J., Chu, Y., Kang, M., Sun, Z., Li, R.-Y., Liao, K., et al. (2016) · Scientific Reports · doi:10.1038/srep27099 · Cited by 34
Nishimoto, A. T., Whaley, S. G., Wiederhold, N. P., Zhang, Q., Yates, C. M., Hoekstra, W. J., Schotzinger, R. J., Garvey, E. P., & Rogers, P. D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01304-19 · Cited by 31
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 34
Statins in candidemia: clinical outcomes from a matched cohort study.
Forrest, G. N., Kopack, A. M., & Perencevich, E. N. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-152 · Cited by 33
Fungal Infections in Transplant and Oncology Patients
Person, A. K., Kontoyiannis, D. P., & Alexander, B. D. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.013 · Cited by 33
Yuan, S., Sun, Y., Xiao, X.-J., Long, Y., & He, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.720926 · Cited by 33
Increased susceptibility to Candida infection following cecal ligation and puncture
Davis, C. G., Chang, K. C., Osborne, D., Walton, A. H., Dunne, W. M., & Muenzer, J. T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.017 · Cited by 33
Skrzypek, F., Cenci, E., Pietrella, D., Rachini, A., Bistoni, F., & Vecchiarelli, A. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.03.010 · Cited by 33
Candida profiles and antifungal resistance evolution over a decade in Lebanon
Araj, G. F., Asmar, R. G., & Avedissian, A. Z. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6550 · Cited by 33
Chen, L.-Y., Liao, S.-Y., Kuo, S., Chen, S.-J., Chen, Y., Wang, F.-D., Yang, S.-P., & Fung, C. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.12.007 · Cited by 33
Metadata
- Authors
- Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Iowa (US)
- Corresponding author
- Diekema, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1172-1177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2118236446
- Cited by
- 1,140
- References
- 37
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 22 · 2023: 30 · 2022: 35 · 2021: 34 · 2020: 35 · 2019: 38 · 2018: 35 · 2017: 51 · 2016: 41 · 2015: 59 · 2014: 74 · 2013: 76 · 2012: 60
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial candidemia, attributable mortality, candidemia, mortality, matched case-control comparison, underlying disease, risk factors, nosocomial infections
- MeSH terms
- Age Factors, Antifungal Agents, Candida, Candidiasis, Cross Infection, Female, Humans, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Sex Factors, Cohort Studies, Fluconazole, Survival Rate, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.